Skip to main content

Table 2 Statistical power for detecting a gene by radiation dose interaction from various study designs

From: Study design: Evaluating gene–environment interactions in the etiology of breast cancer – the WECARE study

 

Proportion of gene carriers = 0.5%

Proportion of gene carriers = 1%

Study design

PP = 100%, PN = 100%

PP = 90%, PN = 90%

PP = 100%, PN = 100%

PP = 90%, PN = 90%

Int RR at 2 Gy

70

100

70

100

16

20

16

20

NCC 3

51

55

48

59

56

63

65

71

CM 1:2

66

67

68

73

75

80

74

76

CM 2:1

32

31

43

45

37

47

48

51

 

Proportion of gene carriers = 2%

Proportion of gene carriers = 3%

Study design

PP = 100%, PN = 100%

PP = 90%, PN = 90%

PP = 100%, PN = 100%

PP = 90%, PN = 90%

Int RR at 2 Gy

8

10

8

10

6

8

6

8

NCC 3

67

84

68

84

73

88

74

89

CM 1:2

78

86

83

86

82

90

80

92

CM 2:1

58

69

71

73

63

79

67

81

 

Proportion of gene carriers = 5%

Proportion of gene carriers = 10%

Study design

PP = 100%, PN = 100%

PP = 90%, PN = 90%

PP = 100%, PN = 100%

PP = 90%, PN = 90%

Int RR at 2 Gy

5

6

5

6

3

4

3

4

NCC 3

81

88

81

91

71

96

72

86

CM 1:2

88

92

88

94

70

95

74

93

CM 2:1

75

87

81

90

64

89

67

83

  1. The power for detecting a gene by radiation dose interaction varies as a function of the proportion of gene carriers, interaction rate ratio at 2 Gy (Int RR at 2 Gy), and predictive positive (PP) and predictive negative (PN) values for registry-noted radiation treatment for true treatment status. These estimates are based on 700 risk sets on a simulation study with 200 trials for each set of parameters. The proportion of registry-noted radiation treated is 40%, and the rate ratio for 2 Gy exposure in non-carriers is 1.5, which corresponds to the 95th centile of a χ2, four degrees of freedom distribution. CM 1:2, counter-matched design in which one member of the triplet is unexposed and two are exposed; CM 2:1, counter-matched design in which two members of the triplet are unexposed and one is exposed; NCC 3, nested case-control study in which each case is randomly matched to two controls.